Trilobatin is a dihydrochalcone glucoside extracted primarily from the leaves of Lithocarpus litseifolius (sweet tea plant), a species native to the mountainous regions of southern China. While it has attracted interest across food science, nutraceutical formulation, and pharmacology, its commercial significance rests on a specific combination of properties that few botanical ingredients can match: zero-calorie high-intensity sweetness, clean sensory profile, and documented bioactivity targeting glucose metabolism. This article covers trilobatin’s chemical identity, its structural relationship to the dihydrochalcone class, its functional properties as a natural sweetener, and the glucose management research that positions both trilobatin and its structural counterpart phlorizin as ingredients of serious scientific interest.
Primary Source: Lithocarpus litseifolius and the Sweet Tea Plant
Trilobatin is found in two plant sources with commercial relevance: Lithocarpus litseifolius (Hance) Chun — also referenced in older literature as Lithocarpus polystachyus Rehder, a synonym for the same species — and Malus trilobata, a wild apple species from the eastern Mediterranean. Of the two, Lithocarpus litseifolius is by far the dominant commercial source. Its tender young leaves, harvested in early spring, accumulate trilobatin at concentrations that can reach 10% or more on a dry-weight basis — a concentration level that makes commercial extraction economically viable at scale.
The plant has been consumed as sweet tea (甜茶, tián chá) in Hunan, Guangxi, and Guizhou provinces for generations, valued both as a refreshing drink and as a traditional remedy for managing blood sugar. In 2017, China’s National Health Commission formally listed L. litseifolius leaves as a new food resource, providing a regulatory framework for their commercial application in food and beverage products. For ingredient buyers, this botanical origin and regulatory history are directly relevant to clean-label claims and traceability documentation.[1]
Dihydrochalcones: The Compound Class Trilobatin Belongs To
Understanding trilobatin requires understanding what a dihydrochalcone is and why this structural class produces both sweetness and bioactivity.
Chalcones are a group of open-chain flavonoids characterized by two aromatic rings connected by a three-carbon enone bridge. Dihydrochalcones are their reduced form — the double bond in the enone bridge has been hydrogenated, producing a saturated ketone linkage. This structural modification fundamentally changes the molecule’s interaction with biological systems, including taste receptors. While chalcones themselves are not typically sweet, their dihydro derivatives bind to the T1R2/T1R3 sweet taste receptor complex with high affinity, producing intense sweetness without contributing caloric value.
Trilobatin is specifically a dihydrochalcone glycoside: a phloretin aglycone backbone with a glucose unit attached at the 4′-O position. The glucose attachment at this specific position is functionally significant — it improves water solubility relative to the free aglycone and moderates metabolic stability, contributing to the cleaner, more sustained sweetness signal that distinguishes trilobatin from structurally related compounds.
| Specification | Detail |
|---|---|
| Common Name | Trilobatin |
| Chemical Name | Phloretin 4′-O-β-D-glucopyranoside |
| CAS Number | 4192-90-9 |
| Molecular Formula | C₂₁H₂₄O₁₀ |
| Molecular Weight | 436.4 g/mol |
| Compound Class | Dihydrochalcone glycoside (flavonoid) |
| Glucose Attachment Position | 4′-O position of phloretin backbone |
| Primary Commercial Source | Lithocarpus litseifolius (sweet tea plant) |
Trilobatin as a Zero-Calorie Natural Sweetener
Trilobatin’s most immediately commercially relevant property is its sweetness intensity. At a 5% sucrose reference concentration, trilobatin delivers approximately 300 times the sweetness of sucrose on a weight basis. Because it is not metabolized for energy by the body in the same way as sugars, it contributes effectively zero calories to a formulation — a distinction that matters directly for products targeting reduced-sugar, low-calorie, and diabetic-friendly positioning.
This places trilobatin in the high-intensity natural sweetener category alongside steviol glycosides and mogrosides, but with a meaningfully different sensory profile. Where stevia often produces bitter or licorice-like aftertastes at higher inclusion rates, trilobatin’s dihydrochalcone structure contributes a rounder, more sugar-like sweetness with lower bitterness and minimal lingering aftertaste. This sensory characteristic makes it useful both as a standalone sweetener and as a co-ingredient that modulates the overall taste profile of stevia or monk fruit-based formulations.[2]
| Property | Trilobatin | Stevia (Reb A) | Sucralose |
|---|---|---|---|
| Caloric value | Zero | Zero | Zero |
| Sweetness vs. sucrose | ~300× | 200–300× | 600× |
| Origin | Botanical (natural) | Botanical (natural) | Synthetic |
| Aftertaste profile | Clean, low bitterness | Bitter/licorice at high dose | Metallic at high dose |
| Clean-label eligible | ✅ | ✅ | ❌ |
| Glucose metabolism activity | ✅ SGLT1/2 inhibition | Indirect only | None documented |
In aqueous beverage applications, trilobatin demonstrates good water solubility and maintains stability across a broad pH range, including acidic matrices typical of functional beverages (pH 3–5). Heat stability supports standard pasteurization protocols, making it technically compatible with most commercial food processing environments.
Trilobatin and Phlorizin: Parallel Dihydrochalcones for Glucose Management
The connection between trilobatin and phlorizin goes beyond structural similarity — both are dihydrochalcones co-occurring in Lithocarpus litseifolius leaf extract, and both target the same glucose transporter mechanism relevant to blood sugar management.
Phlorizin (phloridzin) was the original natural SGLT inhibitor, first isolated from apple tree bark in 1835 and later established as a dual SGLT1/SGLT2 inhibitor through decades of diabetes research. It became the structural template from which modern pharmaceutical SGLT2 inhibitors — including empagliflozin, canagliflozin, and dapagliflozin — were developed, after researchers modified phlorizin’s structure to improve selectivity and oral bioavailability.[3] Phlorizin itself, however, remains a pharmacologically validated natural compound with a well-characterized mechanism: it inhibits sodium-glucose cotransporter proteins, reducing glucose reabsorption in the kidney and slowing glucose absorption in the intestine.
Trilobatin operates through the same SGLT1/SGLT2 inhibitory pathway. Molecular docking studies published in Molecules confirmed that trilobatin fits the active site of both SGLT1 and SGLT2, attenuating glucose uptake in vitro and in vivo in a manner structurally analogous to phlorizin.[4] Separately, research investigating trilobatin’s effect on insulin resistance demonstrated that administration for four weeks significantly reduced fasting blood glucose and serum insulin levels in obese ob/ob mice, improving insulin sensitivity through activation of the IRS-AKT-GLUT4 signaling pathway in skeletal muscle.[5]
For ingredient buyers and formulators, the practical relevance of this parallel is significant. Lithocarpus litseifolius whole-leaf extract naturally contains both compounds. A standardized extract specifying trilobatin content will simultaneously deliver phlorizin, meaning the glucose management positioning of a finished product can draw on mechanistic evidence from both compounds — not just one.
Additional Bioactivity: Antioxidant and Neuroprotective Properties
Trilobatin’s functional profile extends beyond sweetness and glucose metabolism. In vitro studies have documented significant DPPH radical scavenging activity, with IC50 values that position trilobatin competitively within the dihydrochalcone class for antioxidant potency. Oxidative stress is a driver of insulin resistance, cardiovascular disease, and cellular aging — making antioxidant capacity relevant to the same metabolic health positioning that trilobatin’s SGLT inhibition supports.
Preclinical research has also identified neuroprotective effects, including reduced neuroinflammation and mitigation of amyloid-beta-induced cytotoxicity in cell models relevant to neurodegenerative disease research. Anti-inflammatory activity appears to operate through suppression of pro-inflammatory cytokines. These findings are early-stage and require further clinical investigation before forming the basis of product claims, but they broaden the scientific context within which trilobatin is being evaluated by pharmacologists and functional ingredient developers.
Formulation Considerations for B2B Buyers
Trilobatin’s dual role as a zero-calorie sweetener and a bitter-masking agent makes it genuinely multifunctional at the formulation level — one ingredient that addresses both sensory performance and functional positioning simultaneously. When combined with steviol glycosides or mogrosides, the synergistic sweetness enhancement means formulators can reduce the total inclusion rate of all sweetener components while maintaining the target sensory profile, with direct implications for cost-in-use efficiency.
Dosage requirements vary by application format. Beverage applications typically require lower inclusion rates given trilobatin’s high sweetness intensity. Supplement and nutraceutical formats targeting metabolic endpoints may require higher standardized doses to align with the concentrations used in published research. Either way, ingredient specification should reference HPLC-verified trilobatin content rather than relying on crude extract weight, as natural variation in Lithocarpus litseifolius leaf composition means unstandardized extracts will deliver inconsistent sweetness intensity and functional compound concentrations across batches.
Regulatory status should be confirmed for each target market. China’s 2017 novel food resource listing establishes a clear basis for food and beverage applications in the Chinese market. For other markets, buyers should verify current status with their regulatory team, as the category of natural dihydrochalcone sweeteners continues to evolve in both the EU and North American frameworks.
Frequently Asked Questions
What plant does trilobatin come from?
Trilobatin is extracted primarily from the leaves of Lithocarpus litseifolius (Hance) Chun, also known as the sweet tea plant, native to southern China. The same species is referenced in older literature as Lithocarpus polystachyus Rehder — both names refer to the same plant. A second natural source is Malus trilobata, a wild apple species, though it has no significant commercial extraction history compared to the sweet tea plant.
Is trilobatin a zero-calorie sweetener?
Yes. Trilobatin is a non-nutritive high-intensity sweetener that contributes effectively zero calories to a formulation. It delivers approximately 300 times the sweetness of sucrose on a weight basis. Unlike sugars, it is not metabolized for energy in the conventional sense, making it suitable for reduced-calorie and diabetic-friendly product formulations. It is also naturally derived from a botanical source, supporting clean-label positioning.
What is the relationship between trilobatin and phlorizin?
Trilobatin and phlorizin are both dihydrochalcone glycosides that share the same phloretin aglycone backbone. They differ only in the position of the glucose attachment: trilobatin at the 4′-O position, phlorizin at the 2′-O position. Both are naturally present in Lithocarpus litseifolius leaves, and both operate through SGLT1/SGLT2 inhibition relevant to blood glucose management. Phlorizin served as the original natural template for the pharmaceutical development of modern SGLT2 inhibitor drugs.
What is a dihydrochalcone and how does it produce sweetness?
Dihydrochalcones are a subclass of flavonoids derived from chalcones by reduction of the enone double bond. This structural modification allows them to interact with the T1R2/T1R3 sweet taste receptor complex, producing intense sweetness without contributing metabolizable calories. The best-known dihydrochalcone sweetener is neohesperidin dihydrochalcone (NHDC) from citrus. Trilobatin and phlorizin from Lithocarpus litseifolius represent the natural dihydrochalcone pair found in sweet tea extract.
References
[1] Hui L. et al. Chromosome-scale genome assembly of sweet tea (Lithocarpus polystachyus Rehder). Scientific Data, 10, 873 (2023). https://doi.org/10.1038/s41597-023-02791-y
[2] Zheng, J. et al. Antioxidant profiling and quality assessment of Lithocarpus polystachyus sweet tea using LC-ECD and LC-MS/MS. Scientific Reports, 15, 13163 (2025). https://doi.org/10.1038/s41598-025-97875-7
[3] DeFronzo, R.A. SGLT2 inhibitors: cardiorenal metabolic drugs for the ages. Journal of Clinical Investigation, 134(5), e177625 (2024). https://doi.org/10.1172/JCI177625
[4] Wang L . et al. Trilobatin, a Novel SGLT1/2 Inhibitor, Selectively Induces the Proliferation of Human Hepatoblastoma Cells. Molecules, 24(18), 3390 (2019). https://doi.org/10.3390/molecules24183390
[5] Li, Y. et al. Trilobatin ameliorates insulin resistance through IRS-AKT-GLUT4 signaling pathway in C2C12 myotubes and ob/ob mice. Food & Function, 11(10), 8707–8718 (2020). https://10.1186/s13020-020-00390-2.
